This book presents original research results on the leading edge of cancer. Topics discussed include one woman's experience with the Gerson therapy for cancer; epigenetic upregulation or direct over-expression of miR-137 enhances anti-tumour activity of delphinidin for inducing apoptosis in human glioblastoma T98G cells; potentials and challenges of chip technologies in serum biomarker studies for personalised medicine of colorectal cancer; colon cancer; targeting hallmarks of cancer as current therapeutic strategy; and epigenetic regulation of cancer.
| ISBN-13: | 9781631172465 |
| ISBN-10: | 1631172468 |
| Publisher: | Nova Science Publishers, Incorporated |
| Publication date: | 2014-06 |
| Edition description: | UK ed. |
| Pages: | 243 |
| Product dimensions: | Height: 10 Inches, Length: 7 Inches, Weight: 1.2566348934 Pounds, Width: 0.5 Inches |
| Author: | Hiroto S. Watanabe |
| Language: | en |
| Binding: | Hardcover |
Discover more books in the same category
Be the first to review this book!
